Should We Treat Acute HIV Infection?

被引:0
作者
Meagan O’Brien
Martin Markowitz
机构
[1] New York University School of Medicine,Division of Infectious Diseases, Cancer Institute
[2] Aaron Diamond AIDS Research Center,undefined
[3] an affiliate of the Rockefeller University,undefined
来源
Current HIV/AIDS Reports | 2012年 / 9卷
关键词
HIV; Antiretroviral therapy; Clinical trials; Observational studies; Viral load set point; Viral reservoir; Drug-resistant HIV transmission;
D O I
暂无
中图分类号
学科分类号
摘要
Critical advances in the early diagnosis of HIV now allow for treatment opportunities during acute infection. It remains unclear whether treatment of acute HIV infection with antiretroviral therapy improves long-term clinical outcomes for the individual and current guidelines are not definitive in recommending therapy at this stage of infection. However, treatment of acute HIV infection may have short-term benefit on viral set point when compared to delayed therapy as well as reducing the risk of transmission to others. Herein we review the immunological and clinical literature to discuss whether we should treat acute HIV infection, both from the perspective of the individual HIV-infected patient and from the public health perspective. As transmission of drug-resistant HIV variants are of concern, we also review recent clinical trial data to provide recommendations for which specific antiretroviral treatment regimens should be considered for the treatment of acute HIV infection.
引用
收藏
页码:101 / 110
页数:9
相关论文
共 430 条
[1]  
Cohen MS(2011)Acute HIV-1 Infection N Engl J Med 364 1943-1954
[2]  
Shaw GM(2009)Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections J Virol 83 3719-3733
[3]  
McMichael AJ(2009)Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection Antivir Ther 14 321-330
[4]  
Haynes BF(2006)Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection PLoS Med 3 e484-333
[5]  
Stacey AR(2010)Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel JAMA 304 321-1409
[6]  
Norris PJ(2005)Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda J Infect Dis 191 1403-3297
[7]  
Qin L(2009)High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection J Virol 83 3288-2089
[8]  
Haygreen EA(1997)Risk factors and clinical presentation of acute primary HIV infection in India JAMA 278 2085-1450
[9]  
Taylor E(1997)Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia Science 278 1447-39
[10]  
Heitman J(1998)Acute human immunodeficiency virus type 1 infection N Engl J Med 339 33-264